PMH38 THE ECONOMIC IMPACT OF GENERIC SWITCHING FOR PATIENTS WITH MAJOR DESPRESSIVE DISORDER (MDD) TREATED WITH ESCITALOPRAM OR A PATENTED SSRI
Abstract
Authors
V Lauzon A Kaltenboek AP Yu K Ramakrishnan M Marynchenko EQ Wu R Ben-Hamadi MH Erder A Bose